Docosanol
Back to searchMolecule Structure
Scientific Name
Docosanol
Description of the Drug
Docosanol is an antiviral used to treat orofacial herpes sores.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00632
http://www.drugbank.ca/drugs/DB00632
Brand Name(s)
Abreva
Company Owner(s)
P And L Development Llc, Aleor Dermaceuticals Ltd, Glaxosmithkline
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Envelope glycoprotein | PROTEIN FAMILY | INHIBITOR | CHEMBL2364696 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL51925 | |
| PharmGKB | PA164749211 | |
| Human Metabolome Database | HMDB0014770 | |
| DrugBank | DB00632 | |
| PubChem: Thomson Pharma | 14801707 | |
| PubChem | 12620 | |
| Mcule | MCULE-3239333381 | |
| NMRShiftDB | 10008809 | |
| Nikkaji | J45.689F | |
| BindingDB | 50239998 | |
| EPA CompTox Dashboard | DTXSID4027286 | |
| LipidMaps | LMFA05000008 | |
| DrugCentral | 940 | |
| Metabolights | MTBLC31000 | |
| Brenda | 20255 | 90513 |
| ChemicalBook | CB6219657 | |
| SwissLipids | SLM:000001242 | |
| rxnorm | DOCOSANOL | ABREVA |
| PubChem: Drugs of the Future | 12014691 | |
| ChEBI | 31000 | |
| ZINC | ZINC000006920384 |
